Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,804,762
+$256,669 QoQ
Shares Held
7,172
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,045
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Nebraska Trust Co holds $45,421,134 across 9 Drug Manufacturers - General names. ABBV ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,346 | $17,103,863 | |
| 2 | MRK |
Merck & Co., Inc.
|
104,140 | $13,381,990 | |
| 3 | LLY |
ELI LILLY & Co
|
6,923 | $8,303,654 | |
| 4 | PFE |
Pfizer Inc
|
106,986 | $2,576,222 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
7,172 | $1,804,762 | |
| 6 | AMGN |
Amgen Inc
|
2,369 | $857,862 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,907 | $628,461 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,802 | $480,344 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,804,762 | 7,172 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,548,093 | 7,118 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $1,634,388 | 7,153 | Shares | Sole | 2026-06-02 | |
| 2025-09-30 | $1,459,396 | 6,303 | Shares | Sole | 2026-06-09 | |
| 2025-06-30 | $1,169,962 | 6,303 | Shares | Sole | 2026-06-10 | |
| 2025-03-31 | $1,278,700 | 6,103 | Shares | Sole | 2026-06-10 | |
| 2024-12-31 | $1,050,740 | 5,913 | Shares | Sole | 2026-06-12 | |
| 2024-09-30 | $1,167,699 | 5,913 | Shares | Sole | 2026-06-12 | |
| 2024-06-30 | $1,034,780 | 6,033 | Shares | Sole | 2026-06-15 | |
| 2024-03-31 | $1,105,893 | 6,073 | Shares | Sole | 2026-06-16 | |
| 2023-12-31 | $903,165 | 5,828 | Shares | Sole | 2026-06-16 | |
| 2023-09-30 | $865,740 | 5,808 | Shares | Sole | 2026-06-16 | |
| 2023-06-30 | $782,511 | 5,808 | Shares | Sole | 2026-06-17 | |
| 2023-03-31 | $909,683 | 5,708 | Shares | Sole | 2026-06-17 | |
| 2022-12-31 | $903,076 | 5,588 | Shares | Sole | 2026-06-22 | |
| 2022-09-30 | $723,794 | 5,393 | Shares | Sole | 2026-06-22 | |
| 2022-06-30 | $827,064 | 5,400 | Shares | Sole | 2026-06-23 | |
| 2022-03-31 | $880,257 | 5,430 | Shares | Sole | 2026-06-23 | |
| 2021-12-31 | $938,322 | 6,930 | Shares | Sole | 2026-06-24 | |
| 2021-09-30 | $762,964 | 7,073 | Shares | Sole | 2026-06-25 | |
| 2021-06-30 | $779,806 | 6,923 | Shares | Sole | 2026-06-26 | |
| 2021-03-31 | $732,974 | 6,773 | Shares | Sole | 2026-06-26 | |
| 2020-12-31 | $763,015 | 7,121 | Shares | Sole | 2026-06-29 | |
| 2020-09-30 | $652,545 | 7,450 | Shares | Sole | 2026-06-29 | |
| 2020-06-30 | $731,441 | 7,450 | Shares | Sole | 2026-07-01 | |
| 2020-03-31 | $543,463 | 7,133 | Shares | Sole | 2026-07-01 | |
| No filing history on record for this holder in this stock. | ||||||